2.7618
price down icon7.09%   -0.1982
 
loading

Q 32 Bio Inc 주식(QTTB)의 최신 뉴스

pulisher
Dec 11, 2025

Aug Technicals: Can Q32 Bio Inc stock attract ESG capital inflowsQuarterly Profit Review & Verified Momentum Stock Ideas - moha.gov.vn

Dec 11, 2025
pulisher
Dec 07, 2025

Q32 Bio Insiders Benefit From Selling Stock At US$2.86 - simplywall.st

Dec 07, 2025
pulisher
Dec 07, 2025

Stock Market Recap: Why millennials buy Spire Inc LGR stockInsider Buying & Safe Swing Trade Setups - BỘ NỘI VỤ

Dec 07, 2025
pulisher
Dec 05, 2025

Q32 Bio Shares Soar After Offloading Phase 2 Complement Drug to Akebia - MSN

Dec 05, 2025
pulisher
Dec 05, 2025

Q32 Bio Inc. (QTTB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 05, 2025
pulisher
Dec 05, 2025

Is Q32 Bio Inc. stock a defensive play in 2025Quarterly Profit Report & Accurate Technical Buy Alerts - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Is Q32 Bio Inc. stock recession proofWeekly Profit Report & Technical Analysis for Trade Confirmation - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Q32 Bio CEO Morrison sells $77870 in stock By Investing.com - Investing.com South Africa

Dec 05, 2025
pulisher
Dec 04, 2025

Lee Kalowski, Q32 Bio CFO, sells $31k in shares By Investing.com - Investing.com South Africa

Dec 04, 2025
pulisher
Dec 04, 2025

Insider Sell: Lee Kalowski Sells Shares of Q32 Bio Inc (QTTB) - GuruFocus

Dec 04, 2025
pulisher
Dec 04, 2025

Lee Kalowski, Q32 Bio CFO, sells $31k in shares - Investing.com

Dec 04, 2025
pulisher
Dec 04, 2025

CEO Morrison Sells 22,506 ($77.9K) Of Q32 Bio Inc [QTTB] - TradingView

Dec 04, 2025
pulisher
Dec 03, 2025

Synopsys, Moderna, Strategy, Q32 Bio, Wolfspeed: Stocks Making The Biggest Moves Today - MSN

Dec 03, 2025
pulisher
Dec 03, 2025

Deal Watch: Akebia Gets Phase II Alopecia Areata Candidate From Cost-Conscious Q32 - Citeline News & Insights

Dec 03, 2025
pulisher
Dec 02, 2025

Q32 Bio Stock Soars On Selling Experimental Drug To Akeba For Up To $592M - MSN

Dec 02, 2025
pulisher
Dec 02, 2025

Nothing is Better Than Q32 Bio Inc (QTTB) stock at the moment - Setenews

Dec 02, 2025
pulisher
Dec 02, 2025

Block Trades: Will CGEN stock remain a Wall Street favorite2025 Technical Overview & Consistent Profit Alerts - BỘ NỘI VỤ

Dec 02, 2025
pulisher
Dec 02, 2025

QTTB Stock Explodes Nearly 95%: Akebia Deal Transforms Q32 Bio’s Future - Bitget

Dec 02, 2025
pulisher
Dec 02, 2025

Q32 Bio (QTTB) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Dec 02, 2025

Will Q32 Bio Inc. stock attract ESG investorsTrade Analysis Report & Expert Verified Stock Movement Alerts - Newser

Dec 02, 2025
pulisher
Dec 01, 2025

Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook - ts2.tech

Dec 01, 2025
pulisher
Dec 01, 2025

Q32 Bio Sells Complement Inhibitor ADX-097 - citybiz

Dec 01, 2025
pulisher
Dec 01, 2025

Q32 sells rare kidney disease drug to Akebia for $12M up front - BioWorld MedTech

Dec 01, 2025
pulisher
Dec 01, 2025

Q32 Bio Inc. (QTTB) Stock: Jumps on Akebia Acquisition of ADX-097 and Extended Runway - parameter.io

Dec 01, 2025
pulisher
Dec 01, 2025

QTTB Stock Surges: Market Insight - StocksToTrade

Dec 01, 2025
pulisher
Dec 01, 2025

Dow Dips 200 Points; Q32 Bio Shares Jump - inkl

Dec 01, 2025
pulisher
Dec 01, 2025

Why Is Small-Cap Q32 Bio Stock Soaring On Monday? - inkl

Dec 01, 2025
pulisher
Dec 01, 2025

Akebia Therapeutics Sets Rare Kidney Drug Plan After Q32 Bio Deal - marketscreener.com

Dec 01, 2025
pulisher
Dec 01, 2025

Q32 Bio stock rockets after selling Phase 2 complement inhibitor to Akebia - Investing.com Nigeria

Dec 01, 2025
pulisher
Dec 01, 2025

Q32 Bio sells complement inhibitor Adx-097 - marketscreener.com

Dec 01, 2025
pulisher
Dec 01, 2025

Q32 Bio sells complement inhibitor ADX-097 to Akebia for $12M upfront - TipRanks

Dec 01, 2025
pulisher
Dec 01, 2025

Akebia Therapeutics (AKBA) Acquires Phase 2 Drug from Q32 Bio - GuruFocus

Dec 01, 2025
pulisher
Dec 01, 2025

Q32 Bio sells complement inhibitor ADX-097 to Akebia - TipRanks

Dec 01, 2025
pulisher
Dec 01, 2025

Q32 Bio Sells ADX-097 to Akebia Therapeutics - TipRanks

Dec 01, 2025
pulisher
Dec 01, 2025

Akebia Announces Establishment of Rare Kidney Disease Pipeline - The Manila Times

Dec 01, 2025
pulisher
Nov 30, 2025

EBIT per share of Q32 Bio Inc – LSE:0T6G - TradingView

Nov 30, 2025
pulisher
Nov 30, 2025

Cash per share of Q32 Bio Inc – LSE:0T6G - TradingView

Nov 30, 2025
pulisher
Nov 28, 2025

Q32 Bio Inc.Common Stock (Nasdaq:QTTB) Stock Quote - Markets Financial Content

Nov 28, 2025
pulisher
Nov 27, 2025

Form 8-KCurrent report - ADVFN

Nov 27, 2025
pulisher
Nov 25, 2025

Layoff Tracker: Novartis Cuts 550 Employees as Swiss Manufacturing Priorities Shift - BioSpace

Nov 25, 2025
pulisher
Nov 24, 2025

Q32 Bio Inc. Faces Financial Challenges Amid Development Efforts - MSN

Nov 24, 2025
pulisher
Nov 22, 2025

What analysts say about Q32 Bio Inc stockEarnings Volatility Patterns & High Return Trading Plans - earlytimes.in

Nov 22, 2025
pulisher
Nov 21, 2025

Q32 Bio Inc Stock Analysis and ForecastInstitutional Buying Trends & Small Entry Cost Portfolio - earlytimes.in

Nov 21, 2025
$38.34
price down icon 0.56%
$95.77
price down icon 0.35%
$31.65
price up icon 1.23%
$94.53
price down icon 0.30%
biotechnology ONC
$315.54
price down icon 4.01%
$197.91
price up icon 0.18%
자본화:     |  볼륨(24시간):